Loading organizations...
Loading organizations...

Genexa: Manufacturer of over-the-counter medicines using active ingredients without artificial additives, serving families seeking clean alternatives.
Based in Atlanta, Georgia, Genexa is a pharmaceutical manufacturer that produces over-the-counter medicines utilizing the same active ingredients as leading brands but without artificial additives, preservatives, sweeteners, or synthetic dyes. The Certified B Corporation distributes its portfolio of over 35 distinct products through direct-to-consumer channels and more than 60,000 retail locations nationwide, including major national retail partners such as Walmart, Target, and CVS. Operating within the $40 billion over-the-counter pharmaceutical market, the enterprise formulates alternatives for children's pain relief, adult antacids, and allergy management while maintaining a B Impact Score of 94.2. To support its ongoing expansion and retail distribution strategy, Genexa has raised $60 million in total funding from a diverse syndicate of investors that includes Unilever Ventures and Gwyneth Paltrow. The pharmaceutical organization was founded in 2014 by David Johnson and Max Spielberg.
Genexa has raised $60.0M across 1 funding round.
Genexa has raised $60.0M in total across 1 funding round.
Genexa is a healthcare technology company that specializes in producing "clean" over-the-counter medicines made with the same effective active ingredients as leading brands but without artificial additives such as preservatives, dyes, sweeteners, and common allergens. Founded by two fathers, Genexa aims to provide safer, more transparent medicine options for families who want effective symptom relief without unnecessary artificial ingredients. Their products serve consumers seeking trustworthy, clean alternatives in the medicine aisle, addressing concerns about artificial fillers in conventional medicines. The company has gained recognition for innovation, including being named to Fast Company's World's Most Innovative Companies list in 2022, and has demonstrated growth momentum through venture capital funding and expanding product lines[1][3].
Genexa was founded by two dads motivated by their personal desire to revolutionize the medicine aisle by removing artificial ingredients from medicines while maintaining efficacy. The idea emerged from their concern about the unnecessary additives in common medicines and the lack of clean alternatives. Early traction included successfully developing patented formulas that replace artificial fillers with organic and simple ingredients like organic agave syrup and blueberry flavor, while retaining the same active pharmaceutical ingredients. This approach helped Genexa carve out a niche in the clean medicine movement and gain endorsements from healthcare providers who appreciate the transparency and safety of their products[1][3].
Genexa rides the growing consumer trend toward wellness, clean-label products, and transparency in healthcare. The timing is favorable as more consumers demand natural and non-toxic alternatives in everyday products, including medicines. Market forces such as increased awareness of artificial additives' potential health risks and a shift toward preventive health support Genexa’s growth. By pioneering clean over-the-counter medicines, Genexa influences the broader pharmaceutical and wellness ecosystem, encouraging innovation and higher standards for ingredient transparency and safety in medicine manufacturing[1][3].
Looking ahead, Genexa is positioned to expand its product portfolio and market reach as consumer demand for clean, effective medicines grows. Trends such as personalized health, natural wellness, and regulatory scrutiny on artificial additives will likely shape their journey. Their influence may extend beyond OTC medicines into broader healthcare innovation, potentially inspiring competitors and regulators to adopt cleaner standards. Genexa’s commitment to putting people over everything suggests continued innovation and leadership in the clean medicine movement, reinforcing their role as a trusted brand for health-conscious consumers[1][3].
Genexa has raised $60.0M in total across 1 funding round.
Genexa's investors include Jared Stein, Footprint Coalition, Presight Capital, Sound Ventures, Alison Engel, Brandon Shainfeld, Gwyneth Paltrow, Hadi Partovi, Jeffrey Wilke, Marc Benioff, Mark Cuban, Angela Fletcher.
Genexa has raised $60.0M across 1 funding round. Most recently, it raised $60.0M Series A in July 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2021 | $60.0M Series A | Jared Stein | Footprint Coalition, Presight Capital, Sound Ventures, Alison Engel, Brandon Shainfeld, Gwyneth Paltrow, Hadi Partovi, Jeffrey Wilke, Marc Benioff, Mark Cuban, Angela Fletcher, Bridgid Coulter Cheadle, Chris Pratt, Donald Glover, Don Cheadle, Jennifer Meyer, Katherine Schwarzenegger, Lana Parrilla, Lily Aldridge, Patrick Schwarzenegger, Regina Hall, Sanaa Lathan, Tony Kanal, Zoey Deutch, North Castle Partners, Point King Capital, Unilever Ventures, Verlinvest |